Summary
Quest Diagnostics Incorporated (DGX) filed an 8-K on July 24, 2006, primarily to report its financial results for the second quarter and the first half of 2006. The filing incorporates by reference a press release issued on the same date, which contains the detailed financial and operational performance for the periods ending June 30, 2006. Investors should note that this 8-K serves as a notification of the release of these earnings. The substantive details of the company's performance, including revenue, profitability, and any forward-looking statements or management commentary, would be found within the attached press release (Exhibit 99.1), which is incorporated by reference. This filing is a standard procedure for publicly traded companies to disseminate timely financial information to the market.
Key Highlights
- 1Quest Diagnostics (DGX) filed an 8-K on July 24, 2006, reporting its financial results.
- 2The report covers the financial performance for the quarter and six months ended June 30, 2006.
- 3A press release dated July 24, 2006, containing these results, is attached as Exhibit 99.1 and incorporated by reference.
- 4The filing falls under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).
- 5The Chief Financial Officer, Robert A. Hagemann, signed the report, indicating official dissemination of financial information.
- 6This 8-K serves as the official mechanism for Quest Diagnostics to publicly announce its quarterly and semi-annual financial performance.